| Revenue | DKK 8,2M | +151% |
| EBITDA | DKK 8,2M | +151% |
| Net profit | DKK 3,5M | +34% |
| Total assets | DKK 111,6M | +53% |
| Equity | DKK 4M | +804% |
| Employees | — | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -158 | -2.955 | -1.044 | 1.561 | 4.373 | -6.365 | 3.264 | 8.202 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -158 | -2.955 | -1.044 | 1.561 | 4.373 | -6.365 | 3.264 | 8.202 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -10 | -47 | -551 | -2.495 |
| EBIT | -158 | -2.955 | -1.044 | 1.561 | 4.364 | -6.412 | 2.713 | 5.707 |
| Net financials | 0 | -1 | -3 | -20 | -65 | -121 | -78 | -1.814 |
| Profit before tax | -158 | -2.956 | -1.046 | 1.541 | 4.298 | -6.532 | 2.635 | 3.893 |
| Tax | -0 | -842 | -24 | 263 | 818 | -0 | -1 | 364 |
| Net profit | -158 | -2.113 | -1.022 | 1.278 | 3.481 | -6.532 | 2.636 | 3.529 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 224 | 2.177 | 2.507 | 3.011 | 29.689 | 34.516 | 72.725 | 111.595 |
| Equity | -108 | -2.221 | -3.244 | 855 | 4.335 | -2.197 | 439 | 3.968 |
| Long-term debt | 0 | 4.121 | 3.436 | 0 | 0 | 16.131 | 43.069 | 41.671 |
| Short-term debt | 333 | 277 | 2.315 | 2.157 | 25.354 | 20.582 | 29.217 | 65.956 |
| Total debt | 333 | 4.398 | 5.750 | 2.157 | 25.354 | 36.713 | 72.286 | 107.627 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MR Management | Management | 2017 | — | — |
SJ Management | Management | 2024 | — | — |
BB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Apoteka ApS | Company | 100.0% | 100.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Martin Reippurt Glesner | Management | 0 companies |
| Simon Juul Hansen | Management | 0 companies |
| Brian Brorsbøl | Chief Executive Officer | 0 companies |